Genta/Aventis Begins Genasense Expanded Access Program For Melanoma Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
Oblimersen is available to patients with stage IV and unresectable stage III melanoma who have not been previously treated with dacarbazine or temozolomide-containing chemotherapy regimens.